Jon D Campbell
Chief Science Officer, National Pharmaceutical Council
Jon D Campbell is listed as Chief Science Officer, National Pharmaceutical Council. Jon spoke at ISPOR Europe 2026 in November 2026 (speaker, “Delay or Prepare? Navigating EU HTA in the Era of MFN-Driven Launch Uncertainty”). Speaks mainly at Government Administration events.
Compiled from published conference agendas; not yet confirmed by Jon. Is this you? Claim this profile.
- Sector: Government Administration
About
Jon D. Campbell, MS, PhD, is the Chief Science Officer (CSO) of the National Pharmaceutical Council (NPC), which conducts policy-relevant research and communicates it with impact. As CSO, Dr. Campbell leads NPC’s research agenda in concert with NPC’s board and research team. After training at the University of Washington, he joined the faculty at the University of Colorado Anschutz Medical Campus, earning multiple appointments in Pharmacy and Public Health. Dr. Campbell is an author of over 350 manuscripts and abstracts in the field of health economics and health policy research. He holds an adjunct faculty appointment within the Center for Evaluation of Value and Risk in Health at Tufts University School of Medicine.
Sessions at 1 conference
ISPOR Europe 2026 8 November 2026 – 11 November 2026
- Delay or Prepare? Navigating EU HTA in the Era of MFN-Driven Launch Uncertainty Speaker · 10 November 2026
Spoke alongside
People who have shared a session with Jon at events on B2DB.
- Eric C Faulkner President/Founder · SymetryML 1 shared session
- Gregory Daniel Vice President, Head of Public Policy Innovation, Evidence, and Engagement · Eli Lilly and Company 1 shared session
- Joerg Ruof 1 shared session